Patients with higher BCMA expression from their CD138+ plasma cells also have elevated BCMA levels in autologous plasmacytoid dendritic cells, further supporting the patho-biological role of BCMA in MM. This evidence concerns the gene SDC1 and Miyoshi myopathy.